Alere expands POC diabetes offering with Arriva buy
This article was originally published in Clinica
Executive Summary
IVD company Alere has bulked up its point-of-care (POC) diabetes offerings with the acquisition of Arriva Medical, a specialist in home delivery of diabetes testing supplies. The transaction, which is subject to working capital and other closing adjustments entails a $65m cash payment plus 806,452 restricted shares of Alere stock.